ARTICLE | Clinical News
PharmaMar preclinical data
April 25, 2005 7:00 AM UTC
In a mouse xenograft model of lung cancer, PM01217 significantly reduced tumor volume by day 2 or 3 and the reduction was about 40% by day 14 compared to control. PM01217 is an antitumor agent isolate...